These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 11295927

  • 1. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
    Chaine B, Neonato MG, Girot R, Aractingi S.
    Arch Dermatol; 2001 Apr; 137(4):467-70. PubMed ID: 11295927
    [Abstract] [Full Text] [Related]

  • 2. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.
    Nzouakou R, Bachir D, Lavaud A, Habibi A, Lee K, Lionnet F, Hulin A, Jouault H, Préhu C, Roudot-Thoraval F, Girot R, Galactéros F.
    Acta Haematol; 2011 Oct; 125(3):145-52. PubMed ID: 21196716
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
    Tavakkoli F, Nahavandi M, Wyche MQ, Castro O.
    Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.
    Altura RA, Wang WC, Wynn L, Altura BM, Altura BT.
    J Pediatr; 2002 May; 140(5):565-9. PubMed ID: 12032523
    [Abstract] [Full Text] [Related]

  • 11. Leg ulcer induced by hydroxycarbamide in sickle cell disease: What is the therapeutic impact?
    Soya E, Makowski C, Blaise S.
    Int Wound J; 2019 Aug; 16(4):897-902. PubMed ID: 30916480
    [Abstract] [Full Text] [Related]

  • 12. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea.
    Friedrisch JR, Prá D, Maluf SW, Bittar CM, Mergener M, Pollo T, Kayser M, da Silva MA, Henriques JA, da Rocha Silla LM.
    Mutat Res; 2008 Jan 08; 649(1-2):213-20. PubMed ID: 17988936
    [Abstract] [Full Text] [Related]

  • 13. Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease.
    Huang Y, Ananthakrishnan T, Eid JE.
    Am J Hematol; 2003 Oct 08; 74(2):125-6. PubMed ID: 14508799
    [Abstract] [Full Text] [Related]

  • 14. When should hydroxyurea be used for children with sickle cell disease?
    Mueller BU.
    Pediatrics; 2008 Dec 08; 122(6):1365-6. PubMed ID: 19047256
    [No Abstract] [Full Text] [Related]

  • 15. Hydroxyurea for children with sickle cell disease.
    Heeney MM, Ware RE.
    Pediatr Clin North Am; 2008 Apr 08; 55(2):483-501, x. PubMed ID: 18381097
    [Abstract] [Full Text] [Related]

  • 16. Hydroxyurea in children: present and future.
    Vichinsky EP.
    Semin Hematol; 1997 Jul 08; 34(3 Suppl 3):22-9. PubMed ID: 9317198
    [Abstract] [Full Text] [Related]

  • 17. Sickle cell leg ulcers: a frequently disabling complication and a marker of severity.
    Halabi-Tawil M, Lionnet F, Girot R, Bachmeyer C, Lévy PP, Aractingi S.
    Br J Dermatol; 2008 Feb 08; 158(2):339-44. PubMed ID: 18047512
    [Abstract] [Full Text] [Related]

  • 18. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
    Tripathi A, Jerrell JM, Stallworth JR.
    Pediatr Blood Cancer; 2011 Jan 08; 56(1):90-4. PubMed ID: 20922765
    [Abstract] [Full Text] [Related]

  • 19. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE.
    J Pediatr; 2001 Dec 08; 139(6):790-6. PubMed ID: 11743503
    [Abstract] [Full Text] [Related]

  • 20. Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective.
    Sharef SW, Al-Hajri M, Beshlawi I, Al-Shahrabally A, Elshinawy M, Zachariah M, Mevada ST, Bashir W, Rawas A, Taqi A, Al-Lamki Z, Wali Y.
    Eur J Haematol; 2013 Jun 08; 90(6):519-24. PubMed ID: 23489171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.